Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday

Applied DNA Sciences (NASDAQ:APDN) is anticipated to issue its Q2 2025 quarterly earnings data before the market opens on Friday, May 9th. Analysts expect the company to announce earnings of ($3.00) per share and revenue of $1.19 million for the quarter.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings data on Thursday, February 13th. The technology company reported ($28.00) EPS for the quarter, missing the consensus estimate of ($16.00) by ($12.00). Applied DNA Sciences had a negative net margin of 228.12% and a negative return on equity of 101.57%.

Applied DNA Sciences Stock Up 3.0 %

Shares of Applied DNA Sciences stock opened at $0.91 on Friday. The firm has a market capitalization of $1.00 million, a P/E ratio of -0.16 and a beta of 0.86. The company has a 50 day moving average price of $2.63 and a 200 day moving average price of $7.43. Applied DNA Sciences has a 52 week low of $0.72 and a 52 week high of $237.50.

Analyst Ratings Changes

Separately, StockNews.com started coverage on shares of Applied DNA Sciences in a research report on Monday, March 17th. They issued a “sell” rating for the company.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.